BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9756620)

  • 41. Scanning mutagenesis studies reveal multiple distinct regions within the human protein kinase C alpha regulatory domain important for phorbol ester-dependent activation of the enzyme.
    Guo B; Reed K; Parissenti AM
    J Mol Biol; 2006 Mar; 357(3):820-32. PubMed ID: 16460753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of protein kinase C(alpha) by dequalinium analogues: dependence on linker length and geometry.
    Qin D; Sullivan R; Berkowitz WF; Bittman R; Rotenberg SA
    J Med Chem; 2000 Apr; 43(7):1413-7. PubMed ID: 10753478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility.
    Ng T; Parsons M; Hughes WE; Monypenny J; Zicha D; Gautreau A; Arpin M; Gschmeissner S; Verveer PJ; Bastiaens PI; Parker PJ
    EMBO J; 2001 Jun; 20(11):2723-41. PubMed ID: 11387207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY; Repasky E; Liu HT
    Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration.
    Dubois T; Mira JP; Feliers D; Solito E; Russo-Marie F; Oudinet JP
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1277-82. PubMed ID: 9494097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of epidermal growth factor-like domain of NELL proteins in the novel protein-protein interaction with protein kinase C.
    Kuroda S; Tanizawa K
    Biochem Biophys Res Commun; 1999 Nov; 265(3):752-7. PubMed ID: 10600492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterization of protein kinase C-alpha binding to lamin A.
    Martelli AM; Bortul R; Tabellini G; Faenza I; Cappellini A; Bareggi R; Manzoli L; Cocco L
    J Cell Biochem; 2002; 86(2):320-30. PubMed ID: 12112001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting of protein kinase Calpha to caveolae.
    Mineo C; Ying YS; Chapline C; Jaken S; Anderson RG
    J Cell Biol; 1998 May; 141(3):601-10. PubMed ID: 9566962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state.
    Bornancin F; Parker PJ
    J Biol Chem; 1997 Feb; 272(6):3544-9. PubMed ID: 9013603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central role of PKCα in isoenzyme-selective regulation of cardiac transient outward current Ito and Kv4.3 channels.
    Scholz EP; Welke F; Joss N; Seyler C; Zhang W; Scherer D; Völkers M; Bloehs R; Thomas D; Katus HA; Karle CA; Zitron E
    J Mol Cell Cardiol; 2011 Nov; 51(5):722-9. PubMed ID: 21803046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of lipid on the structure and phosphorylation of protein kinase C alpha substrate peptides.
    Vinton BB; Wertz SL; Jacob J; Steere J; Grisham CM; Cafiso DS; Sando JJ
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1433-42. PubMed ID: 9494117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
    Qian H; Pipolo L; Thomas WG
    Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new mechanism of action of a C2 domain-derived novel PKC inhibitor peptide.
    Farah CA; Sossin WS
    Neurosci Lett; 2011 Oct; 504(3):306-10. PubMed ID: 21982802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein kinase Calpha expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells.
    Cho Y; Talmage DA
    Exp Cell Res; 2001 Sep; 269(1):97-108. PubMed ID: 11525643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of the regulatory domain of protein kinase C alpha exposes regions in the hinge and catalytic domains that mediate nuclear targeting.
    James G; Olson E
    J Cell Biol; 1992 Feb; 116(4):863-74. PubMed ID: 1734020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation.
    Garcia-Paramio P; Cabrerizo Y; Bornancin F; Parker PJ
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):631-6. PubMed ID: 9677322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain.
    Sakane F; Kai M; Wada I; Imai S; Kanoh H
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):583-90. PubMed ID: 8809050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the Ca2+/phosphatidylserine binding region of the C2 domain in the translocation of protein kinase Calpha to the plasma membrane.
    Bolsover SR; Gomez-Fernandez JC; Corbalan-Garcia S
    J Biol Chem; 2003 Mar; 278(12):10282-90. PubMed ID: 12525479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of peptide probes directed against PKCalpha conformations.
    Ashraf SS; Anderson E; Duke K; Hamilton PT; Fredericks Z
    J Pept Res; 2003 May; 61(5):263-73. PubMed ID: 12662360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of dequalinium chloride troche in oral region (author's transl)].
    Shimura K; Shindo J; Kamata H; Yamaguchi T; Kurozu T
    Nihon Koku Geka Gakkai Zasshi; 1975; 21(6):803-5. PubMed ID: 1073433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.